Omnicell Inc (OMCL)
27.43
-1.00
(-3.52%)
USD |
NASDAQ |
Apr 24, 16:00
27.44
+0.01
(+0.04%)
Pre-Market: 20:00
Omnicell Cash from Investing (TTM): -55.02M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -55.02M |
September 30, 2023 | -59.90M |
June 30, 2023 | -61.58M |
March 31, 2023 | -53.58M |
December 31, 2022 | -58.67M |
September 30, 2022 | -233.80M |
June 30, 2022 | -411.57M |
March 31, 2022 | -418.10M |
December 31, 2021 | -412.50M |
September 30, 2021 | -456.80M |
June 30, 2021 | -273.14M |
March 31, 2021 | -279.22M |
December 31, 2020 | -279.87M |
September 30, 2020 | -58.08M |
June 30, 2020 | -62.93M |
March 31, 2020 | -58.74M |
December 31, 2019 | -61.66M |
September 30, 2019 | -59.66M |
June 30, 2019 | -58.25M |
March 31, 2019 | -56.53M |
December 31, 2018 | -54.37M |
September 30, 2018 | -52.36M |
June 30, 2018 | -45.22M |
March 31, 2018 | -42.69M |
December 31, 2017 | -34.99M |
Date | Value |
---|---|
September 30, 2017 | -72.08M |
June 30, 2017 | -73.91M |
March 31, 2017 | -68.30M |
December 31, 2016 | -341.32M |
September 30, 2016 | -297.63M |
June 30, 2016 | -297.12M |
March 31, 2016 | -321.35M |
December 31, 2015 | -45.60M |
September 30, 2015 | -46.58M |
June 30, 2015 | -64.03M |
March 31, 2015 | -41.84M |
December 31, 2014 | -43.32M |
September 30, 2014 | -44.78M |
June 30, 2014 | -24.52M |
March 31, 2014 | -20.80M |
December 31, 2013 | -20.45M |
September 30, 2013 | -21.28M |
June 30, 2013 | -23.74M |
March 31, 2013 | -172.43M |
December 31, 2012 | -168.71M |
September 30, 2012 | -163.82M |
June 30, 2012 | -167.23M |
March 31, 2012 | -10.32M |
December 31, 2011 | -13.07M |
September 30, 2011 | -21.24M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-456.80M
Minimum
Sep 2021
-53.58M
Maximum
Mar 2023
-179.63M
Average
-61.66M
Median
Dec 2019
Cash from Investing (TTM) Benchmarks
Teladoc Health Inc | -156.35M |
American Shared Hospital Services | -6.273M |
Novo Integrated Sciences Inc | -- |
Astrana Health Inc | -65.52M |
Cryo-Cell International Inc | -7.284M |